|
|
|
SCHEDULE YOUR TIME:
|
|
Network at the INTERPHEX
Week Tokyo 2026
|
|
May 20 (Wed) - 22 (Fri), 2026
|
|
Booth #2-31, Makuhari Messe, Japan
|
|
|
|
|
|
|
| We’re heading to INTERPHEX Week Tokyo 2026, from May 20 (Wed) to May 22 (Fri), 2026. Visit us at booth #2-31 to discuss your upcoming development needs and areas of mutual interest. We would be honored to invite you to register as VIP visitor for free to enjoy the benefits as below. Limited seats available. Register now to secure your spot.
|
| *VIP Benefits:
|
- Free access to up to three paid conference sessions.
- Access to the VIP Lounge within the exhibition venue.
|
| We look forward to meeting you at INTERPHEX Week in Tokyo to explore how our capabilities
can support your current and future programs.
|
| |
|
|
On-demand Webinar: Reducing Viral Clearance Challenges Through Preventative Measures
|
|
Despite existing regulatory guidelines, designing a VC study is often not as
straightforward as you might expect. In this webinar you’ll be given an in-depth look
at some of the challenges you may encounter and the steps you can take to ensure viral
clearance study success.
|
|
|
|
|
| |
|
|
Viral Safety and Viral Clearance Summit Resources
|
|
Watch our 2025 Summit recap video from Cologne, Germany, to learn key industry
insights. Gain insight from industry experts, academic researchers, and expert
regulatory authorities as they explore new technologies, best practices, and how to
design an efficient manufacturing process.
|
|
|
|
|
| |
|
|
Viral Clearance Studies
|
|
Are you confident your viral clearance studies fully evaluate the risk for viral
contamination in your drug manufacturing process? With over 30 years of experience
designing and performing viral clearance projects, we can provide you with
intelligent, tailored study designs and timely reports.
|
|
|
|
|
| |
|
|
Multi-Spiking for Viral Clearance Studies
|
|
The time and resources required for viral spiking can often stress deadlines and
budgets. Our cutting-edge multi-spike approaches expertly combines testing for two
viruses in a single run. Designed for ultra-efficiency, this new process can deliver
faster, more cost-effective viral clearance studies for your biopharmaceutical
products.
|
|
|
|
|
| |
|
|
Medical Device Viral Inactivation Testing
|
|
Human/animal tissues and their derivatives are utilized in medical devices and their
presence could lead to viral contamination and negatively affect patients using them.
Ensure your devices are free of potential viruses and harmful pathogens with our
comprehensive viral inactivation testing program and deliver the safest version of
your device to patients.
|
|
|
|
|
| |
|
©2026 Charles River Laboratories International, Inc.
|
|
Privacy
Policy
|
|
Charles River Laboratories | 1.877.274.8371 | 251 Ballardvale St. | Wilmington, MA | 01887
|
|
